UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation Journal article
Zhou,Jing Bo, Tang,Dongyang, He,Lin, Lin,Shiqi, Lei,Josh Haipeng, Sun,Heng, Xu,Xiaoling, Deng,Chu Xia. Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation[J]. Pharmacological Research, 2023, 194, 106830.
Authors:  Zhou,Jing Bo;  Tang,Dongyang;  He,Lin;  Lin,Shiqi;  Lei,Josh Haipeng; et al.
Favorite | TC[WOS]:8 TC[Scopus]:9  IF:9.1/9.0 | Submit date:2023/08/03
Bortezomib (Pubchem Cid: 387447)  Cepharanthine (Pubchem Cid: 10206)  Docetaxel (Taxotere) (Pubchem Cid: 11970251)  Drug Combination Therapy  Flunarizine Dihydrochloride (Pubchem Cid: 5282407)  Lapatinib Ditosylate (Pubchem Cid: 9941095)  Machine Learning  Pazopanib Hydrochloride (Pubchem Cid: 11525740)  Potential Combination Biomarkers  Tamoxifen Citrate (Pubchem Cid: 2733525)  Three-dimensional Tumor Slice Culture  Vatalanib (Pubchem Cid: 151194)  Vincristine (Pubchem Cid: 5978)  Xl-184 (Cabozantinib) (Pubchem Cid: 25102847)  
Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism Journal article
Shim J.S., Li R.-J., Lv J., Head S.A., Yang E.J., Liu J.O.. Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism[J]. Cancer Letters, 2015, 362(1), 106-115.
Authors:  Shim J.S.;  Li R.-J.;  Lv J.;  Head S.A.;  Yang E.J.; et al.
Favorite | TC[WOS]:25 TC[Scopus]:25 | Submit date:2019/01/15
Angiogenesis  Cholesterol Trafficking  Selective Estrogen Receptor Modulator  Tamoxifen  
Furanodiene enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells in a PPARγ independent manner Journal article
Zhong, ZF, Li, YB, Wang, SP, Tan, W, Chen, XP, Chen, MW, Wang, YT. Furanodiene enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells in a PPARγ independent manner[J]. Journal of Cellular Biochemistry, 2012, 2643-2651.
Authors:  Zhong, ZF;  Li, YB;  Wang, SP;  Tan, W;  Chen, XP; et al.
Favorite | TC[WOS]:31 TC[Scopus]:31  IF:3.0/3.1 | Submit date:2022/07/27
Furanodiene  Tamoxifen  Breast Cancer  Cell Cycle  Apoptosis  Pparγ  
Furanodiene enhances tamoxifen‐induced growth inhibitory activity of ERa‐positive breast cancer cells in a PPARγ independent manner Journal article
Zhong Z.-F., Li Y.-B., Wang S.-P., Tan W., Chen X.-P., Chen M.-W., Wang Y.-T.. Furanodiene enhances tamoxifen‐induced growth inhibitory activity of ERa‐positive breast cancer cells in a PPARγ independent manner[J]. Journal of Cellular Biochemistry, 2012, 113(8), 2643.
Authors:  Zhong Z.-F.;  Li Y.-B.;  Wang S.-P.;  Tan W.;  Chen X.-P.; et al.
Favorite | TC[WOS]:31 TC[Scopus]:31  IF:3.0/3.1 | Submit date:2018/10/31
Apoptosis  Breast Cancer  Cell Cycle  Furanodiene  Pparγ  Tamoxifen